Correction for “TLR4‐MAP4K4 signaling pathway in models of oxygen‐induced retinopathy,” by Wenwen Chen, Juan Zhang, Peijun Zhang, Fangyuan Hu, Tingting Jiang, Junxiang Gu, and Qing Chang, which was first published in November 26, 2018; 10.1096/fj.201801086R (FASEB J. 33, 3451–3464).

The authors note that there is a composition error in Figure 7. In the color keys for the bar graphs, the identifying colors for shMAP4K4 and ranibizumab treatment are reversed in panel A, and the colors for LPS + shMAP4K4 and LPS + ranibizumab treatment are reversed in panel B. The graphs themselves are correct.

The correct figure and legend are as follows:

陈文文，张娟，张培军，胡芳媛，姜婷婷，顾俊祥和常青的``TLR4-MAP4K4信号通路在氧致视网膜病变模型中的校正''，于2018年11月26日首次发布; 10.1096 / fj.201801086R（FASEBĴ。33，3451-3464）。

作者注意到，图7中存在成分错误。在条形图的颜色键中，面板A颠倒了shMAP4K4和ranibizumab处理的识别颜色，而LPS + shMAP4K4和LPS + ranibizumab处理的颜色则颠倒了。在图B中。图形本身是正确的。

正确的图形和图例如下：